{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:25:47Z","timestamp":1793139947072,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T00:00:00Z","timestamp":1709942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T00:00:00Z","timestamp":1709942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-024-04820-w","type":"journal-article","created":{"date-parts":[[2024,3,9]],"date-time":"2024-03-09T12:01:47Z","timestamp":1709985707000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Association between chronic prostatitis and the subsequent benign prostatic hyperplasia: a population-based national cohort study"],"prefix":"10.1007","volume":"42","author":[{"given":"Tsung-Yen","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I-Hung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han-Yu","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Chiao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Hui","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Yi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3981-8657","authenticated-orcid":false,"given":"Yu-Sheng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,9]]},"reference":[{"issue":"Suppl 1","key":"4820_CR1","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.1016\/j.ijantimicag.2007.08.028","volume":"31","author":"JN Krieger","year":"2008","unstructured":"Krieger JN, Lee SW, Jeon J et al (2008) Epidemiology of prostatitis. Int J Antimicrob Agents 31(Suppl 1):S85. https:\/\/doi.org\/10.1016\/j.ijantimicag.2007.08.028","journal-title":"Int J Antimicrob Agents"},{"key":"4820_CR2","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1016\/j.biopha.2017.08.016","volume":"94","author":"FU Khan","year":"2017","unstructured":"Khan FU, Ihsan AU, Khan HU et al (2017) Comprehensive overview of prostatitis. Biomed Pharmacother 94:1064\u20131076. https:\/\/doi.org\/10.1016\/j.biopha.2017.08.016","journal-title":"Biomed Pharmacother"},{"key":"4820_CR3","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1016\/S0022-5347(01)63564-X","volume":"159","author":"MM Collins","year":"1998","unstructured":"Collins MM, Stafford RS, O\u2019Leary MP et al (1998) How common is prostatitis? A national survey of physician visits. J Urol 159:1224\u20131228. https:\/\/doi.org\/10.1016\/S0022-5347(01)63564-X","journal-title":"J Urol"},{"key":"4820_CR4","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/s0022-5347(05)68562-x","volume":"162","author":"MS Litwin","year":"1999","unstructured":"Litwin MS, McNaughton-Collins M, Fowler FJ Jr et al (1999) The National Institutes of Health chronic prostatitis symptom index: development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol 162:369\u2013375. https:\/\/doi.org\/10.1016\/s0022-5347(05)68562-x","journal-title":"J Urol"},{"key":"4820_CR5","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/S0090-4295(98)00034-X","volume":"51","author":"RO Roberts","year":"1998","unstructured":"Roberts RO, Lieber MM, Rhodes T et al (1998) Prevalence of a physician-assigned diagnosis of prostatitis: the Olmsted County Study of Urinary Symptoms and Health Status Among Men. Urology 51:578\u2013584. https:\/\/doi.org\/10.1016\/S0090-4295(98)00034-X","journal-title":"Urology"},{"key":"4820_CR6","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1111\/j.1464-410X.2004.05002.x","volume":"94","author":"CZ Liang","year":"2004","unstructured":"Liang CZ, Zhang XJ, Hao ZY et al (2004) An epidemiological study of patients with chronic prostatitis. BJU Int 94:568\u2013570. https:\/\/doi.org\/10.1111\/j.1464-410X.2004.05002.x","journal-title":"BJU Int"},{"key":"4820_CR7","doi-asserted-by":"publisher","first-page":"7984","DOI":"10.1038\/s41598-017-06628-8","volume":"7","author":"SWH Lee","year":"2017","unstructured":"Lee SWH, Chan EMC, Lai YK (2017) The global burden of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a systematic review and meta-analysis. Sci Rep 7:7984. https:\/\/doi.org\/10.1038\/s41598-017-06628-8","journal-title":"Sci Rep"},{"key":"4820_CR8","doi-asserted-by":"publisher","first-page":"155798832110367","DOI":"10.1177\/15579883211036786","volume":"15","author":"XF Xu","year":"2021","unstructured":"Xu XF, Liu GX, Guo YS et al (2021) Global, regional, and national incidence and year lived with disability for benign prostatic hyperplasia from 1990 to 2019. Am J Mens Health 15:15579883211036786. https:\/\/doi.org\/10.1177\/15579883211036786","journal-title":"Am J Mens Health"},{"key":"4820_CR9","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1159\/000496289","volume":"65","author":"S Madersbacher","year":"2019","unstructured":"Madersbacher S, Sampson N, Culig Z (2019) Pathophysiology of benign prostatic hyperplasia and benign prostatic enlargement: a mini-review. Gerontology 65:458\u2013464. https:\/\/doi.org\/10.1159\/000496289","journal-title":"Gerontology"},{"key":"4820_CR10","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/bju.12118","volume":"112","author":"G Gandaglia","year":"2013","unstructured":"Gandaglia G, Briganti A, Gontero P et al (2013) The role of chronic prostatic inflammation in the pathogenesis and progression of benign prostatic hyperplasia (BPH). BJU Int 112:432\u2013441. https:\/\/doi.org\/10.1111\/bju.12118","journal-title":"BJU Int"},{"key":"4820_CR11","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/nrurol.2016.168","volume":"13","author":"C De Nunzio","year":"2016","unstructured":"De Nunzio C, Presicce F, Tubaro A (2016) Inflammatory mediators in the development and progression of benign prostatic hyperplasia. Nat Rev Urol 13:613\u2013626. https:\/\/doi.org\/10.1038\/nrurol.2016.168","journal-title":"Nat Rev Urol"},{"key":"4820_CR12","unstructured":"Ning X, Shi JP, Wu ZY et al (2003) A case-control study on the risk factors of benign prostatic hyperplasia in the suburb of Shenyang; article in Chinese. Zhonghua Liu Xing Bing Xue Za Zhi 24:276\u2013280. https:\/\/rs.yiigle.com\/cmaid\/678920"},{"key":"4820_CR13","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/j.urology.2007.11.155","volume":"71","author":"JL St Sauver","year":"2008","unstructured":"St Sauver JL, Jacobson DJ, McGree ME et al (2008) Longitudinal association between prostatitis and development of benign prostatic hyperplasia. Urology 71:475\u2013479. https:\/\/doi.org\/10.1016\/j.urology.2007.11.155","journal-title":"Urology"},{"key":"4820_CR14","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1080\/13685538.2018.1434772","volume":"22","author":"AE Calogero","year":"2019","unstructured":"Calogero AE, Burgio G, Condorelli RA et al (2019) Epidemiology and risk factors of lower urinary tract symptoms\/benign prostatic hyperplasia and erectile dysfunction. Aging Male 22:12\u201319. https:\/\/doi.org\/10.1080\/13685538.2018.1434772","journal-title":"Aging Male"},{"key":"4820_CR15","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s11255-008-9338-7","volume":"40","author":"MR Safarinejad","year":"2008","unstructured":"Safarinejad MR (2008) Prevalence of benign prostatic hyperplasia in a population-based study in Iranian men 40 years old or older. Int Urol Nephrol 40:921\u2013931. https:\/\/doi.org\/10.1007\/s11255-008-9338-7","journal-title":"Int Urol Nephrol"},{"key":"4820_CR16","doi-asserted-by":"publisher","first-page":"268","DOI":"10.4306\/pi.2015.12.2.268","volume":"12","author":"JS Koh","year":"2015","unstructured":"Koh JS, Ko HJ, Wang SM et al (2015) The Relationship between depression, anxiety, somatization, personality and symptoms of lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Psychiatry Investig 12:268\u2013273. https:\/\/doi.org\/10.4306\/pi.2015.12.2.268","journal-title":"Psychiatry Investig"},{"key":"4820_CR17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-015581","volume":"7","author":"YH Peng","year":"2017","unstructured":"Peng YH, Huang CW, Liao WC et al (2017) Association between chronic obstructive pulmonary disease and increased risk of benign prostatic hyperplasia: a retrospective nationwide cohort study. BMJ Open 7:e015581. https:\/\/doi.org\/10.1136\/bmjopen-2016-015581","journal-title":"BMJ Open"},{"key":"4820_CR18","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/s41391-018-0047-8","volume":"21","author":"WM Li","year":"2018","unstructured":"Li WM, Pasaribu N, Lee SS et al (2018) Risk of incident benign prostatic hyperplasia in patients with gout: a retrospective cohort study. Prostate Cancer Prostatic Dis 21:277\u2013286. https:\/\/doi.org\/10.1038\/s41391-018-0047-8","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"4820_CR19","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1080\/13685538.2018.1552253","volume":"23","author":"YH Peng","year":"2020","unstructured":"Peng YH, Huang CW, Chou CY et al (2020) Association between asthma and risk of benign prostatic hyperplasia: a retrospective population-based study. Aging Male 23:599\u2013606. https:\/\/doi.org\/10.1080\/13685538.2018.1552253","journal-title":"Aging Male"},{"key":"4820_CR20","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s11325-022-02617-y","volume":"27","author":"JF Huang","year":"2023","unstructured":"Huang JF, Shen N, Zhao JM et al (2023) Relationship between severity of obstructive sleep apnea and benign prostatic hyperplasia. Sleep Breath 27:363\u2013369. https:\/\/doi.org\/10.1007\/s11325-022-02617-y","journal-title":"Sleep Breath"},{"key":"4820_CR21","doi-asserted-by":"publisher","first-page":"d12","DOI":"10.2741\/a171","volume":"2","author":"CA Feghali","year":"1997","unstructured":"Feghali CA, Wright TM (1997) Cytokines in acute and chronic inflammation. Front Biosci 2:d12-26. https:\/\/doi.org\/10.2741\/a171","journal-title":"Front Biosci"},{"key":"4820_CR22","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/s0022-5347(17)49698-4","volume":"132","author":"SJ Berry","year":"1984","unstructured":"Berry SJ, Coffey DS, Walsh PC et al (1984) The development of human benign prostatic hyperplasia with age. J Urol 132:474\u2013479. https:\/\/doi.org\/10.1016\/s0022-5347(17)49698-4","journal-title":"J Urol"},{"key":"4820_CR23","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.urology.2013.05.009","volume":"82","author":"NN Maserejian","year":"2013","unstructured":"Maserejian NN, Chen S, Chiu GR et al (2013) Incidence of lower urinary tract symptoms in a population-based study of men and women. Urology 82:560\u2013564. https:\/\/doi.org\/10.1016\/j.urology.2013.05.009","journal-title":"Urology"},{"key":"4820_CR24","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1111\/j.1442-2042.2006.01347.x","volume":"13","author":"KL Toh","year":"2006","unstructured":"Toh KL, Ng CK (2006) Urodynamic studies in the evaluation of young men presenting with lower urinary tract symptoms. Int J Urol 13:520\u2013523. https:\/\/doi.org\/10.1111\/j.1442-2042.2006.01347.x","journal-title":"Int J Urol"},{"key":"4820_CR25","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1159\/000502765","volume":"103","author":"F Chiancone","year":"2019","unstructured":"Chiancone F, Carrino M, Meccariello C et al (2019) The use of a combination of vaccinium macracarpon, Lycium barbarum L. and Probiotics (Bifiprost\u00ae) for the prevention of chronic bacterial prostatitis: a double-blind randomized study. Urol Int 103:423\u2013426. https:\/\/doi.org\/10.1159\/000502765","journal-title":"Urol Int"},{"key":"4820_CR26","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.1007\/s00345-020-03580-7","volume":"39","author":"T Cai","year":"2021","unstructured":"Cai T, Gallelli L, Cione E et al (2021) The use of Lactobacillus casei DG\u00ae prevents symptomatic episodes and reduces the antibiotic use in patients affected by chronic bacterial prostatitis: results from a phase IV study. World J Urol 39:3433\u20133440. https:\/\/doi.org\/10.1007\/s00345-020-03580-7","journal-title":"World J Urol"},{"key":"4820_CR27","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1249\/MSS.0000000000000472","volume":"47","author":"R Zhang","year":"2015","unstructured":"Zhang R, Chomistek AK, Dimitrakoff JD et al (2015) Physical activity and chronic prostatitis\/chronic pelvic pain syndrome. Med Sci Sports Exerc 47:757\u2013764. https:\/\/doi.org\/10.1249\/MSS.0000000000000472","journal-title":"Med Sci Sports Exerc"},{"key":"4820_CR28","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12894-017-0211-9","volume":"17","author":"M Gacci","year":"2017","unstructured":"Gacci M, Sebastianelli A, Salvi M et al (2017) Benign prostatic enlargement can be influenced by metabolic profile: results of a multicenter prospective study. BMC Urol 17:22. https:\/\/doi.org\/10.1186\/s12894-017-0211-9","journal-title":"BMC Urol"},{"key":"4820_CR29","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1080\/13685538.2018.1487392","volume":"23","author":"HJ Shih","year":"2020","unstructured":"Shih HJ, Tsai PS, Wen YC et al (2020) Hyperlipidemia patients with long-term statin treatment are associated with a reduced risk of progression of benign prostatic enlargement. Aging Male 23:354\u2013361. https:\/\/doi.org\/10.1080\/13685538.2018.1487392","journal-title":"Aging Male"},{"key":"4820_CR30","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1002\/pros.22623","volume":"73","author":"L Vignozzi","year":"2013","unstructured":"Vignozzi L, Gacci M, Cellai I et al (2013) Fat boosts, while androgen receptor activation counteracts, BPH-associated prostate inflammation. Prostate 73:789\u2013800. https:\/\/doi.org\/10.1002\/pros.22623","journal-title":"Prostate"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-024-04820-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-024-04820-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-024-04820-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T21:22:07Z","timestamp":1735852927000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-024-04820-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,9]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4820"],"URL":"https:\/\/doi.org\/10.1007\/s00345-024-04820-w","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,9]]},"assertion":[{"value":"20 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of National Cheng Kung University Hospital, Tainan, Taiwan (Date 2019.11.28\/No. B-ER-108-346).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"126"}}